GENETIS LAORATORY TEST REQUEST FORM - …
Shodair hildren’s Hospital Genetics Laboratory 2755 olonial Dr, Helena. MT, 59601 Phone (406) 444-7532 Toll Free (800) 447-6614 Fax (406) 444-1022 email: mtgene@shodair.org
Download GENETIS LAORATORY TEST REQUEST FORM - …
Information
Domain:
Source:
Link to this page:
Related documents
DRUG NAME: Carboplatin
www.bccancer.bc.caCarboplatin DRUG NAME: Carboplatin SYNONYM(S): CBDCA, JM8, NSC 241240 COMMON TRADE NAME(S): PARAPLATIN®, PARAPLATIN-AQ® CLASSIFICATION: Alkylating agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
Gem-Cisp: Gemcitabine/Cisplatin in Relapsed …
www.londoncanceralliance.nhs.ukReason for Update: Network Protocol Development Gemcitabine. should be used with caution in patients with impaired renal function: CrCl (ml/min) Gemcitabine Dose
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
www.medsafe.govt.nzNew Zealand Data Sheet 16 October 2017 Lasix and Lasix High Dose- furosemide (frusemide) lasix-lasix-high-dose-ccdsv12-dsv15-16oct17 Page 1
Protocol: Carboplatin/Gemcitabine
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 1 Protocol: Carboplatin/Gemcitabine Indications: Lung Cancer (non-small cell) - Advanced
Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 62 Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin) ...
LESSON ASSIGNMENT LESSON 6 Drugs Used to …
www.sweethaven02.comMD0913 6-3 c. Cautions and Warnings. (1) This drug should be used cautiously in pregnant women because of the fact that it can cross the placenta and cause ototoxicity (see d (1) below) in the fetus.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.pharma.us.novartis.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBI Podhaler safely and effectively. See full prescribing information for TOBI